An intersectional human rights approach to prioritising access to COVID-19 vaccines

Author:

Sekalala SharifahORCID,Perehudoff Katrina,Parker Michael,Forman LisaORCID,Rawson Belinda,Smith Maxwell

Abstract

We finally have a vaccine for the COVID-19 crisis. However, due to the limited numbers of the vaccine, states will have to consider how to prioritise groups who receive the vaccine. In this paper, we argue that the practical implementation of human rights law requires broader consideration of intersectional needs in society and the disproportionate impact that COVID-19 is having on population groups with pre-existing social and medical vulnerabilities. The existing frameworks/mechanisms and proposals for COVID-19 vaccine allocation have shortcomings from a human rights perspective that could be remedied by adopting an intersectional allocative approach. This necessitates that states allocate the first COVID-19 vaccines according to (1) infection risk and severity of pre-existing diseases; (2) social vulnerabilities; and (3) potential financial and social effects of ill health. In line with WHO’s guidelines on universal health coverage, a COVID-19 vaccine allocation strategy that it is more consistent with international human rights law should ensure that vaccines are free at the point of service, give priority to the worst off and be allocated in a transparent, participatory and accountable prioritisation process.

Publisher

BMJ

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference53 articles.

1. European Centre for Disease Prevention and Control . Overview of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA and the UK, 2020. Available: https://www.ecdc.europa.eu/en/publications-data/overview-current-eu-eea-uk-plans-covid-19-vaccines [Accessed 8 Feb 2021].

2. The World Health Organization (WHO) . Press release: more than 150 countries engaged in COVID-19 vaccine global access facility. Geneva: The World Health Organization (WHO), 2020.

3. WHO . WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination. Geneva: WHO, 2020.

4. Nuffield Council on Bioethics . Rapid policy Briefing: fair and equitable access to COVID-19 treatments and vaccines. London: Nuffield Council on Bioethics, 2020.

5. An ethical framework for global vaccine allocation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3